Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Jacksonville, Florida · 2255 DUNN AVE STE 206, JACKSONVILLE, FL 32218-4739 · (904) 201-9658
Part of Exelixis Clinical
As of July 2026, 2 paid clinical trials are recruiting at Exelixis Clinical in Jacksonville, Florida. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (2)
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for Advanced Solid Tumor
13 locations incl. Jacksonville
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05932862·Phase 1·Recruiting·Listed Jul 2023
More research sites in Jacksonville
- Mayo Clinic in Florida (174 trials)
- Mayo Clinic (81 trials)
- Mayo Clinic Florida (72 trials)
- Mayo Clinic Jacksonville (42 trials)
- Nemours Children's Clinic-Jacksonville (32 trials)
- Jacksonville Center for Clinical Research (21 trials)
- Baptist MD Anderson Cancer Center (17 trials)
- Cancer Specialists of North Florida (13 trials)
- University of Florida (13 trials)
- Brooks Rehabilitation (9 trials)
Explore more
Paid clinical trials in Jacksonville, FL · Florida clinical trials